Latest news
CRC 1530 Seminar Series: Maximilian Merz, MD
Speaker: Maximilian Merz, Memorial SloanKettering Cancer Center, New York
Host: Hyatt Balke-Want
More information coming soon.
CRC 1530 Seminar Series: Marc Schmidt-Supprian, PhD
Speaker: Marc Schmidt-Supprian, TranslaTUM - Center for translational Cancer Research, Technical University of Munich, Immunopathologie and Signal…
CRC 1403 x CRC 1530 Seminar: Peter Czabotar, PhD
CRC 1530 Retreat
More information coming soon.
CRC 1530 Retreat
More information coming soon.
CRC 1530 Seminar Series: Heinz Jacobs, PhD
Speaker: Heinz Jacobs PhD, The Netherlands Cancer Institute, Amsterdam, Research Group Programmed Mutagenesis
Talk: EPIGENETICALLYPROGRAMMED…
CRC 1530 Coffee Break ☕ with Mila Daoud
K: Hi Mila, please introduce yourself, and tell us about your scientific background and your current research.
M: Hello, my name is Mila Daoud. I'm…
Cell death isn’t the end, it’s a crucial decision point
Congratulations to two CRC 1530 papers fresh of the press!
With the new funding period just started, we are excited to share the most recent paper of CRC1530
Abstract:
Caspase-3 (CASP3) and caspase-7 (CASP7) are the two major executioner caspases that are proteolytically activated by upstream initiator…
CRC 1530 Coffee Break ☕ with Sebastian Scheich
Kristie: Hi Sebastian, could you tell us a bit about yourself and what you're researching right now?
Sebastian: Hello, my name is Sebastian Scheich.…
Latest news
New publication on overcoming fratricide in CD86-targeted CAR-T cell therapy
Abstract:
Despite its remarkable success in the treatment of several…
CRC 1530 Gender Equity Spotlight: From Competence to Confidence - Making Your Expertise Visible
We are pleased to host this special keynote, which takes place as part of the…
CRC 1530 Double Feature: Talk by Fleur Peters + Lymphoma Tech Meeting
We are pleased to invite you to an exciting CRC 1530 Double Feature on 16 June.
…